Intellia Therapeutics, Inc. (NTLA)

Intellia Therapeutics Statistics

Total Valuation

NTLA has a market cap or net worth of $885.64 million. The enterprise value is $297.79 million.

Market Cap	885.64M
Enterprise Value	297.79M

Important Dates

The last earnings date was Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

NTLA has 103.58 million shares outstanding. The number of shares has increased by 11.19% in one year.

Current Share Class	103.58M
Shares Outstanding	103.58M
Shares Change (YoY)	+11.19%
Shares Change (QoQ)	+1.62%
Owned by Insiders (%)	1.36%
Owned by Institutions (%)	91.37%
Float	98.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.92
Forward PS	n/a
PB Ratio	1.14
P/TBV Ratio	1.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.90, with a Debt / Equity ratio of 0.15.

Current Ratio	4.90
Quick Ratio	4.57
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -57.92% and return on invested capital (ROIC) is -33.05%.

Return on Equity (ROE)	-57.92%
Return on Assets (ROA)	-30.12%
Return on Invested Capital (ROIC)	-33.05%
Return on Capital Employed (ROCE)	-61.94%
Revenue Per Employee	$113,074
Profits Per Employee	-$1.30M
Employee Count	403
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.04% in the last 52 weeks. The beta is 2.33, so NTLA's price volatility has been higher than the market average.

Beta (5Y)	2.33
52-Week Price Change	-65.04%
50-Day Moving Average	8.26
200-Day Moving Average	14.42
Relative Strength Index (RSI)	54.14
Average Volume (20 Days)	3,287,539

Short Selling Information

The latest short interest is 28.75 million, so 27.75% of the outstanding shares have been sold short.

Short Interest	28.75M
Short Previous Month	28.51M
Short % of Shares Out	27.75%
Short % of Float	29.20%
Short Ratio (days to cover)	7.57

Income Statement

In the last 12 months, NTLA had revenue of $45.57 million and -$525.91 million in losses. Loss per share was -$5.21.

Revenue	45.57M
Gross Profit	-417.32M
Operating Income	-541.07M
Pretax Income	-508.80M
Net Income	-525.91M
EBITDA	-530.80M
EBIT	-541.07M
Loss Per Share	-$5.21

Balance Sheet

The company has $503.75 million in cash and $119.25 million in debt, giving a net cash position of $587.85 million or $5.68 per share.

Cash & Cash Equivalents	503.75M
Total Debt	119.25M
Net Cash	587.85M
Net Cash Per Share	$5.68
Equity (Book Value)	779.92M
Book Value Per Share	7.53
Working Capital	438.80M

Cash Flow

In the last 12 months, operating cash flow was -$377.15 million and capital expenditures -$4.01 million, giving a free cash flow of -$381.16 million.

Operating Cash Flow	-377.15M
Capital Expenditures	-4.01M
Free Cash Flow	-381.16M
FCF Per Share	-$3.68

Margins

Gross Margin	n/a
Operating Margin	-1,187.36%
Pretax Margin	-1,154.10%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NTLA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.19%
Shareholder Yield	-11.19%
Earnings Yield	-59.38%
FCF Yield	-43.04%

Analyst Forecast

The average price target for NTLA is $38.60, which is 351.46% higher than the current price. The consensus rating is "Buy".

Price Target	$38.60
Price Target Difference	351.46%
Analyst Consensus	Buy
Analyst Count	20
Revenue Growth Forecast (5Y)	104.26%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NTLA has an Altman Z-Score of 0.79 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.79
Piotroski F-Score	2